Home
Conditions
Skin Diseases, Papulosquamous

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Completed

Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis

NCT00236119

Conditions: Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations: Wake Forest University Winston-Salem, North Carolina, United States

Texas Dermatology Rsch Inst Dallas, Texas, United States

Viginia Clinical Research Norfolk, Virginia, United States

View Trial Details

Completed

Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis

NCT01591070

Conditions: Dermatitis, Dermatitis, Seborrheic, Sebaceous Gland Diseases, +5 more
Locations: Department of dermatology, Pusan National University Hospital Busan, South Korea

View Trial Details

Completed

Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy

NCT00303186

Conditions: Arthritis, Arthritis, Psoriatic, Psoriasis, Arthritis, Rheumatoid, +10 more
Locations: Pfizer Investigational Site Cagliari, Italy

Pfizer Investigational Site Naples, Campania, Italy

Pfizer Investigational Site Prato, FI - Italy, Italy

Pfizer Investigational Site Florence, Italy

View Trial Details

Completed

Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis

NCT01077882

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +20 more
Locations: University Hospital Ghent Ghent, Belgium

View Trial Details

Completed

HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis

NCT00830908

Conditions: Dermatitis, Dermatitis, Seborrheic, Sebaceous Gland Diseases, +5 more
Locations: Mediprobe Research Inc London, Ontario, Canada

View Trial Details

Completed

Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice

NCT01147874

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations: Modern Research Assoc. PLLC Dallas, Texas, United States

Rheumatology Practive of Scott Zashin, MD Dallas, Texas, United States

Center for Clinical Studies Ltd LLP Houston, Texas, United States

Rheumatology Associates of Houston Houston, Texas, United States

View all 45 locations

View Trial Details

Completed

Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy

NCT00581555

Conditions: Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis

NCT00852761

Conditions: Plaque-type Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations: Wake Forest University Health Sciences Department of Dermatology Winston-Salem, North Carolina, United States

View Trial Details

Completed

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

NCT00663052

Conditions: Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations: Pfizer Investigational Site Capital Federal, Buenos Aires, Argentina

Pfizer Investigational Site Capital Federal, Buenos Aires, Argentina

Pfizer Investigational Site San Miguel, Buenos Aires, Argentina

Pfizer Investigational Site Feldkirch, Austria

View all 38 locations

View Trial Details

Completed

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

NCT00936065

Conditions: Moderate to Severe Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations: Pfizer Investigational Site Daejeon, Korea, South Korea

Pfizer Investigational Site Gyeonggido, Korea, South Korea

Pfizer Investigational Site Seoul, Korea, South Korea

Pfizer Investigational Site Seoul, Korea, South Korea

View Trial Details

Skin Diseases, Papulosquamous

Skin Diseases, Papulosquamous trial results

Related conditions